NEW YORK, Oct. 7-Aspira Biosystems has been granted a patent for its capture agents for proteins, a technique that the company plans to use to develop sequence-specific protein capture arrays.
The patent covers a method developed by Aspira co-founder Chin-Shiou Huang to create cavities for capturing macromolecules. With this method, a template molecule is used to create specific cavities in a solidified material such as mixture of polymers.
Aspira plans to use this technique to profile known and novel proteins in parallel from biological samples.
The U.S. Patent and Trade Office granted the patent on Oct. 1. For further details on the technique, see the patent.
Aspira is a privately held company based in South San Francisco, Calif.